Eastman Chemical Company cash flow to debt ratio of 19.11% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Eastman Chemical Company's free cash flow has decreased 38.37% from $688.00M last year to $424.00M, signaling decreasing performance

Eastman Chemical Company's debt to equity ratio is 0.86, which means that the company's assets are unhealthy financed, signaling financial risk.

Eastman Chemical Company's debt has decreased relative to shareholder equity from 0.91 last year to 0.86 today, signaling strengthened financials

Eastman Chemical Company has a net debt to EBITDA ratio of 3.50x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Eastman Chemical Company's interest coverage ratio of 3.93 indicates that earnings with good margin can cover interest payments on company debt

Eastman Chemical Company's profit margin has decreased (48.31%) in the last year from 9.65% to 4.99%, signaling decreasing performance

Eastman Chemical Company's short-term assets of $3.65B exceed its short-term liabilities of $2.65B

Eastman Chemical Company's return on assets of 2.87% is lower than the 5.00% threshold, indicating inefficient asset utilization

Eastman Chemical Company's return on equity of 7.42%, is lower than 15.00%, indicating bad performance

Eastman Chemical Company's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Eastman Chemical Company had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Eastman Chemical Company has positive free cash flow, indicating the company generates cash after capital expenditures

Eastman Chemical Company has a free cash flow yield of 5.05%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Eastman Chemical Company's yearly earnings has decreased 47.62% since last year from $905.00M to $474.00M, signaling decreasing performance

Eastman Chemical Company's yearly revenue has decreased 6.64% since last year from $9.37B to $8.75B, signaling decreasing performance

ROIC 5.14% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Eastman Chemical Company's 3-year revenue CAGR of -5.99% is negative, indicating declining revenue over the past 3 years

Eastman Chemical Company had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Eastman Chemical Company had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Eastman Chemical Company has insufficient data to evaluate this check.

Eastman Chemical Company has an earnings yield of 5.27%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Eastman Chemical Company is overvalued relative to its fair value price of 39.46 based on EBITDA multiple model

Eastman Chemical Company has an EV/EBITDA ratio of 10.01x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Eastman Chemical Company is undervalued relative to its fair value price of 75.80 based on Earnings Fair Value model

Eastman Chemical Company has a PEG-ratio over 1 which is considered overvalued

Eastman Chemical Company has a price-to-book ratio of 1.36x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Eastman Chemical Company has a price-to-sales ratio of 0.95x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue